Skip to main content
. 2015 Mar 4;45(4):1393–1399. doi: 10.1590/s1517-83822014000400033

Figure 4.

Figure 4

Antibacterial properties of BZT nanoparticle on E. coli, K. pneumoniae, M. luteus and S. aureus. (K is the abbreviation for standard 30 μg/mL kanamycin and A, B and C show BZT in the concentration of 2, 5 and 10 μg/mL respectively.)